CUPERTINO, Calif.--(BUSINESS WIRE)--ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and…
Team to Drive Strategic Initiatives, Launching Efforts at 2024 ACOG MeetingATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq:…
MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;…
Ovaterra's new formula is the first prenatal vitamin in the U.S. market to provide 100% of the essential nutrients a…
-- The Phase 2b study planned to be conducted in 15 clinical sites in the United States -- -- Topline…
Preliminary results from the Company’s ongoing Phase 2/3 study expected in the first half of 2025WOODCLIFF LAKE, N.J., April 30,…
Organon, a global women’s healthcare company, initiated XACIATO™ commercial activities in the fourth quarter of 2023 XOMA further expands its…
An automated outbreak detection tool reduced the size of outbreaks by 64% in the trial period preceding the COVID-19 pandemic…
Algorithm driven alerts help identify best antibiotic for patients with common infections in two 59-hospital trials, with implications to reduce…